14th Jul 2023 08:25
MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in the production and development of plant-derived medicines - Conditionally raises GBP650,000, before expenses, through a placing and subscription of 541.7 million shares at a price of 0.12 pence per share. This represents a 57% discount from the closing price of 0.28p per share on Wednesday. The company also raises GBP50,000 from its Chief Executive Officer & Managing Director Roby Zomer in a convertible loan agreement. Read More
